Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Dysbiosis

• Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor
• INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM"
• The Influence of Probiotics on Metabolome and Heart Rate Variability in Heart Failure of Structure Heart Disease
• Impact of Probiotics on Gut Microbiome During Antibiotic Prophylaxis in Elective Orthopedic Surgery
• Probiotics in the Prevention of Recurrent Prosthetic Joint Infection of the Hip and Knee
• Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma
• Fecal Microbiota Transplantation in Axial Spondyloarthritis
• Fecal Microbiota Transplantation by Oral Capsules for Hepatic Encephalopathy Treatment
• Study of the Safety and Tolerability of the Broad-spectrum Probiotic Medicine "AS-Probionorm"
• Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17
• Oral Iron Supplementation for Patients With Chronic Kidney Disease
• A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis
• Effect of Probiotic (VSL#3) on Gut Microbiome and Bacterial Translocation in Healthy Asian Volunteers
• Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting.
• The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication
• Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis
• Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial
• Tongue Dysbiosis Effects on Arterial Pressure of Periodontitis Patients
• The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.
• Fecal Microbiota Transplantation for Treatment of Gastrointestinal Dysbiosis Clearance of ARO
• Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication
• Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD)
• PPI and Microbiome in Healthy Volunteers and Functional Dyspepsia
• SHIFT: Studying HIV Immunology After Fecal Transplant
• PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients
• A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
• Longitudinal Study of the Human Intestinal Microbiome